140 related articles for article (PubMed ID: 37656231)
1. Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction.
Heiat M; Rezaei E; Gharechahi J; Abbasi M; Behroozi J; Abyazi MA; Baradaran B
Med Oncol; 2023 Sep; 40(10):287. PubMed ID: 37656231
[TBL] [Abstract][Full Text] [Related]
2. IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells.
Han J; Hu X
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616130
[TBL] [Abstract][Full Text] [Related]
3. Combination of SIX4-siRNA and temozolomide inhibits the growth and migration of A-172 glioblastoma cancer cells.
Mohammadpour ZJ; Mohammadzadeh R; Javadrashid D; Baghbanzadeh A; Doustvandi MA; Barpour N; Baradaran B
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2741-2751. PubMed ID: 37093251
[TBL] [Abstract][Full Text] [Related]
4. SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells.
Tang X; Yang Y; Song X; Liu X; Wang X; Huang F; Li Y; Chen F; Wan H
Biochem Biophys Res Commun; 2019 Aug; 516(3):851-857. PubMed ID: 31266633
[TBL] [Abstract][Full Text] [Related]
5. Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin.
Vazirabad AF; Noorolyai S; Baghbani E; Mahboob S; Zargari F; Rahmani S; Sorkhabi A; Montazami N; Sameti P; Baradaran B
Pathol Res Pract; 2022 Dec; 240():154194. PubMed ID: 36370483
[TBL] [Abstract][Full Text] [Related]
6. miR-802 inhibits the proliferation, invasion, and epithelial-mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4.
Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
Cell Biochem Funct; 2020 Jan; 38(1):66-76. PubMed ID: 31702057
[TBL] [Abstract][Full Text] [Related]
7. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis.
Chile T; Fortes MA; Corrêa-Giannella ML; Brentani HP; Maria DA; Puga RD; de Paula Vde J; Kubrusly MS; Novak EM; Bacchella T; Giorgi RR
BMC Cancer; 2013 Oct; 13():451. PubMed ID: 24088503
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinoma.
Li Y; Jiang X; Yan X; Wang Y
Thorac Cancer; 2021 Mar; 12(6):752-759. PubMed ID: 33481352
[TBL] [Abstract][Full Text] [Related]
9. SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer.
Li G; Hu F; Luo X; Hu J; Feng Y
PeerJ; 2017; 5():e3394. PubMed ID: 28584719
[TBL] [Abstract][Full Text] [Related]
10. SIX4 activates Akt and promotes tumor angiogenesis.
Sun X; Hu F; Hou Z; Chen Q; Lan J; Luo X; Wang G; Hu J; Cao Z
Exp Cell Res; 2019 Oct; 383(1):111495. PubMed ID: 31301290
[TBL] [Abstract][Full Text] [Related]
11. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.
Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H
Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879
[TBL] [Abstract][Full Text] [Related]
13. SIX4 upregulates IDH1 and metabolic reprogramming to promote osteosarcoma progression.
Li B; Dang X; Duan J; Zhang G; Zhang J; Song Q
J Cell Mol Med; 2023 Jan; 27(2):259-265. PubMed ID: 36601689
[TBL] [Abstract][Full Text] [Related]
14. SIX4 promotes metastasis through STAT3 activation in breast cancer.
Sun X; Ma J; Chen Q; Hou Z; Luo X; Wang G; Wang J; Hu J; Cao Z
Am J Cancer Res; 2020; 10(1):224-236. PubMed ID: 32064163
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer.
Fang ZX; Li CL; Wu Z; Hou YY; Wu HT; Liu J
World J Gastrointest Oncol; 2022 Nov; 14(11):2138-2156. PubMed ID: 36438701
[TBL] [Abstract][Full Text] [Related]
16. ProNGF siRNA inhibits cell proliferation and invasion of pancreatic cancer cells and promotes anoikis.
Xu J; Song J; Yang X; Guo J; Wang T; Zhuo W
Biomed Pharmacother; 2019 Mar; 111():1066-1073. PubMed ID: 30841420
[TBL] [Abstract][Full Text] [Related]
17. PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways.
Feng J; Ma T; Ge Z; Lin J; Ding W; Chen H; Zhu W; Zhou S; Tan Y
Mol Med Rep; 2015 Mar; 11(3):2111-7. PubMed ID: 25411978
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis.
Liu P; Cai S; Li N
Exp Cell Res; 2020 Sep; 394(2):112141. PubMed ID: 32535033
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4.
Zhang M; Shi H; Zhang C; Zhang SQ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4807-4814. PubMed ID: 31210312
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway.
Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L
Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
